表紙
市場調查報告書

酵素抑制劑的全球市場:產業分析,市場規模·佔有率·成長率·趨勢·未來預測

Global Enzyme Inhibitor Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2018 to 2025

出版商 Value Market Research 商品編碼 838482
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
酵素抑制劑的全球市場:產業分析,市場規模·佔有率·成長率·趨勢·未來預測 Global Enzyme Inhibitor Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2018 to 2025
出版日期: 2019年03月01日內容資訊: 英文
簡介

本報告提供全球酵素抑制劑的市場相關分析,彙整產品概要和市場基本結構,主要的推動及阻礙市場要素,整體市場趨勢預測 (今後8年份),各類型·各地區的詳細趨勢,市場競爭環境,主要企業簡介等調查。

第1章 簡介

第2章 摘要整理

第3章 市場分析

  • 簡介
  • 價值鏈分析
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 波特的五力分析

第4章 酵素抑制劑市場分析:各類型

  • 質子幫浦抑制劑 (PPI)
  • 蛋白分解酵素抑制劑
  • 逆轉錄酵素抑制劑
  • 芳香酶抑制劑
  • 激化酵素抑制劑
  • 神經胺糖酸酶抑制劑
  • Statin
  • 其他

第5章 酵素抑制劑市場分析:各用途

  • 化療
  • 抗生素
  • 農藥
  • 心血管治療
  • 其他

第6章 酵素抑制劑市場分析:各地區

  • 北美市場 (美國,加拿大等)
    • 市場規模的估計價值
    • 市場規模的估計價值:各國
  • 歐洲市場 (英國,德國,法國等)
  • 亞太地區市場 (中國,日本,印度等)
  • 南美市場 (巴西等)
  • 中東·非洲市場

第7章 酵素抑制劑企業:競爭環境

  • 市場競爭
  • 事業聯盟/合作,協定
  • 企業合併·收購 (M&A)
  • 新產品的銷售
  • 其他動向

第8章 酵素抑制劑產業:企業簡介 (企業概要,財務分析,主要產品,近幾年趨勢)

  • Abbott Laboratories Inc.
  • AstraZeneca
  • Bayer
  • GlaxoSmithKline
  • Johnson & Johnson
  • Novartis
  • Ranbaxy Laboratories
  • Roche & Pfizer
  • 武田藥品工業
  • Tentative TOC
目錄

The report on Global Enzyme Inhibitor Market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2018-2025. The market size in terms of revenue (USD MN) is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints).

  • Drivers
    • Growing prevalence of cardiovascular disease, gastrointestinal disease, hepatitis, cancer, diabetes and other chronic medical conditions
    • Stressed work life, poor eating habits, sedentary lifestyle and lack of exercise

Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period:

  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Till: 2025

The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.

The report classifies the market into different segments based on type, and application. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.

The report also covers the complete competitive landscape of the worldwide market with company profiles of key players such as Abbott Laboratories Inc., AstraZeneca, Bayer, GlaxoSmithKline, Johnson & Johnson, Novartis, Ranbaxy Laboratories, Roche & Pfizer and Takeda. A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.

SEGMENTATIONS IN THE REPORT:

By Type:

  • Proton Pump Inhibitors (PPIs)
  • Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Aromatase Inhibitors
  • Kinase Inhibitors
  • Neuraminidase Inhibitors
  • Statins
  • Others

By Applications:

  • Chemotherapy
  • Antibiotics
  • Pesticides
  • Cardiovascular Treatments
  • Others

By Geography:

  • North America (NA) - US, Canada & Rest of North America
  • Europe (EU) - UK, Germany, France & Rest of Europe
  • Asia Pacific (APAC) - China, Japan, India & Rest of APAC
  • Latin America (LA) - Brazil & Rest of Latin America
  • Middle East & Africa (MEA) - Middle East and Africa

Table of Contents

1. INTRODUCTION

  • Report Description
  • Research Scope
  • Research Methodology

2. EXECUTIVE SUMMARY

  • Market Highlight
  • Global Enzyme Inhibitor Market: Snapshot

3. MARKET ANALYSIS

  • Introduction
  • Value Chain Analysis
  • Drivers
  • Restraints
  • Opportunities
  • Porter's Five Forces Analysis

4. ENZYME INHIBITOR MARKET ANALYSIS BY TYPE

  • Market In Proton Pump Inhibitors (PPIs)
  • Market In Protease Inhibitors
  • Market In Reverse Transcriptase Inhibitors
  • Market In Aromatase Inhibitors
  • Market In Kinase Inhibitors
  • Market In Neuraminidase Inhibitors
  • Market In Statins
  • Market In Others

5. ENZYME INHIBITOR MARKET ANALYSIS BY APPLICATION

  • Market In Chemotherapy
  • Market In Antibiotics
  • Market In Pesticides
  • Market In Cardiovascular Treatments
  • Market In Others

6. ENZYME INHIBITOR MARKET ANALYSIS BY GEOGRAPHY

  • North America (NA)
  • North America Market Estimates
  • North America Market Estimates By Country
  • United States (U.S.)
  • Canada
  • Rest Of North America
  • Europe (EU)
  • Europe Market Estimates
  • Europe Market Estimates By Country
  • United Kingdom (UK)
  • Germany
  • France
  • Rest Of Europe
  • Asia Pacific (APAC)
  • Asia Pacific Market Estimates
  • Asia Pacific Market Estimates By Country
  • China
  • Japan
  • India
  • Rest Of Asia Pacific
  • Latin America (LA)
  • Latin America Market Estimates
  • Latin America Market Estimates By Country
  • Brazil
  • Rest Of Latin America
  • Middle East And Africa (MEA)
  • Middle East And Africa Market Estimates
  • Middle East And Africa Market Estimates By Country
  • Middle East
  • Africa

7. COMPETITIVE LANDSCAPE OF THE ENZYME INHIBITOR COMPANIES

  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments

8. COMPANY PROFILES OF THE ENZYME INHIBITOR INDUSTRY (Company Overview, Financial, Major Products & Recent Development)

  • Abbott Laboratories Inc.
  • AstraZeneca
  • Bayer
  • GlaxoSmithKline
  • Johnson & Johnson
  • Novartis
  • Ranbaxy Laboratories
  • Roche & Pfizer
  • Takeda
  • Tentative TOC